Literature DB >> 22850621

Management strategy for multifocal branch duct intraductal papillary mucinous neoplasms of the pancreas.

Yasuhisa Mori1, Takao Ohtsuka, Hiroshi Kono, Noboru Ideno, Teppei Aso, Yosuke Nagayoshi, Shunichi Takahata, Masafumi Nakamura, Kousei Ishigami, Shinichi Aishima, Yoshinao Oda, Masao Tanaka.   

Abstract

OBJECTIVES: Branch duct intraductal papillary mucinous neoplasms of the pancreas (BD-IPMNs) often are composed of multifocal lesions. We aimed to clarify the clinicopathologic features of multifocal BD-IPMNs.
METHODS: Medical records of 211 patients with BD-IPMNs (169 solitary and 42 multifocal) were retrospectively analyzed. We compared the pathological grade of resected IPMNs and the resulting clinical course between solitary and multifocal BD-IPMNs.
RESULTS: Sixty-nine patients (54 with solitary and 15 with multifocal BD-IPMNs) underwent pancreatectomy, and of these patients, 62 exhibited at least 1 malignant predictor. There was no significant difference in the prevalence of malignancy in the resected BD-IPMNs between the 2 groups. In the remaining 142 patients who exhibited no malignant predictors, both groups demonstrated no differences in morphologic changes of BD-IPMNs. Seventeen distinct ductal carcinomas were identified in both groups, and there was no difference in the prevalence of ductal carcinoma between the 2 groups. Moreover, there was no significant difference in the disease-specific survival rate between the 2 groups.
CONCLUSIONS: In patients with multifocal BD-IPMNs, resection is only warranted for lesions that exhibit malignancy predictors; moreover, closer attention to the potential presence or development of distinct ductal carcinoma in patients with multifocal and solitary BD-IPMNs is warranted.

Entities:  

Mesh:

Year:  2012        PMID: 22850621     DOI: 10.1097/MPA.0b013e31824b22c6

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  6 in total

1.  Follow-up of Incidentally Detected Pancreatic Cystic Neoplasms: Do Baseline MRI and CT Features Predict Cyst Growth?

Authors:  Pallavi Pandey; Ankur Pandey; Yan Luo; Mounes Aliyari Ghasabeh; Pegah Khoshpouri; Sanaz Ameli; Anne Marie O'Broin-Lennon; Marcia Canto; Ralph H Hruban; Michael S Goggins; Christopher Wolfgang; Ihab R Kamel
Journal:  Radiology       Date:  2019-07-16       Impact factor: 11.105

Review 2.  Intraductal Papillary Mucinous Neoplasm of the Pancreas: Current Perspectives.

Authors:  Ersin Gürkan Dumlu; Derya Karakoç; Arif Özdemir
Journal:  Int Surg       Date:  2015-06

Review 3.  Prevalence, Diagnosis and Management of Pancreatic Cystic Neoplasms: Current Status and Future Directions.

Authors:  James J Farrell
Journal:  Gut Liver       Date:  2015-09-23       Impact factor: 4.519

4.  Intraductal papillary mucinous neoplasm of the pancreas presenting as a giant abdominal mass: A case report.

Authors:  Abdelhakim Harouachi; Marouane Harhar; Ayoub Kharkhach; Nabil Khomsi; Chafik Rhoul; Tariq Bouhout; Tijani El Harroudi; Badr Serji
Journal:  Ann Med Surg (Lond)       Date:  2022-01-19

Review 5.  Pancreatic Ductal Adenocarcinoma: Molecular Pathology and Predictive Biomarkers.

Authors:  Mehran Taherian; Hua Wang; Huamin Wang
Journal:  Cells       Date:  2022-09-29       Impact factor: 7.666

6.  Sub-branch and mixed-type intraductal papillary mucinous neoplasms of the pancreas: 2 case reports.

Authors:  Zafer Ozmen; Fatma Aktas; İsmail Okan; Zeki Özsoy; Akgül Arıcı
Journal:  Radiol Case Rep       Date:  2016-01-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.